BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 12635815)

  • 1. Interactions of herbs with cytochrome P450.
    Zhou S; Gao Y; Jiang W; Huang M; Xu A; Paxton JW
    Drug Metab Rev; 2003 Feb; 35(1):35-98. PubMed ID: 12635815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
    Drugs Aging; 2005; 22(6):525-39. PubMed ID: 15974642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs-Implication for Herb-Drug Interaction.
    Fasinu PS; Manda VK; Dale OR; Egiebor NO; Walker LA; Khan SI
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29168799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
    Obach RS
    J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal modulation of P-glycoprotein.
    Zhou S; Lim LY; Chowbay B
    Drug Metab Rev; 2004 Feb; 36(1):57-104. PubMed ID: 15072439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
    Hellum BH; Hu Z; Nilsen OG
    Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):23-30. PubMed ID: 17214607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
    Clin Pharmacol Ther; 2002 Sep; 72(3):276-87. PubMed ID: 12235448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal interactions involving cytochrome p450 enzymes: a mini review.
    Delgoda R; Westlake AC
    Toxicol Rev; 2004; 23(4):239-49. PubMed ID: 15898829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDR- and CYP3A4-mediated drug-herbal interactions.
    Pal D; Mitra AK
    Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions.
    Hermann R; von Richter O
    Planta Med; 2012 Sep; 78(13):1458-77. PubMed ID: 22855269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).
    Wanwimolruk S; Prachayasittikul V
    EXCLI J; 2014; 13():347-91. PubMed ID: 26417265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions between herbal remedies and medicinal drugs.
    Ioannides C
    Xenobiotica; 2002 Jun; 32(6):451-78. PubMed ID: 12160480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS; Black SR; Patel PR; So J; Mathews JM
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herb-drug interactions and mechanistic and clinical considerations.
    Chen XW; Sneed KB; Pan SY; Cao C; Kanwar JR; Chew H; Zhou SF
    Curr Drug Metab; 2012 Jun; 13(5):640-51. PubMed ID: 22292789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.